Opinion: After 50 years of ‘health crisis,’ chuck the Chicken Little rhetoric
Although Americans love anniversaries, we have overlooked the political importance of July 10, 1969. Speaking…
Author: STAT
STAT Plus: ‘Pause button’ for CAR-T cells may overcome a dangerous side effect of cancer therapy
Two separate research teams have found a “pause button” for CAR-T cell therapy, which may…
Everyone agrees this superbug is a threat. Few are willing to fund research to stop it
In the universe of scary drug-resistant pathogens that can kill, Candida auris is having a…
A family’s medical mystery sheds light on the surprising ways disease-causing genes can be inherited
To her family, Tatiana Legkiy looked completely healthy when she was born. But a pediatrician…
STAT Plus: Experimental gene therapy for hemophilia, developed by Pfizer and Sangamo, shows early promise
A one-time hemophilia A treatment from Pfizer (PFE) and Sangamo Therapeutics (SGMO) showed promising results…
Trump plans drug pricing executive order aimed at ensuring U.S. pays less than other nations
WASHINGTON — President Trump on Friday said his administration would soon issue an executive order…
STAT Plus: Glaxo’s ViiV Healthcare tussles with Kazakhstan over an AIDS drug
In a bid to gain access to a costly AIDS drug sold by ViiV Healthcare,…
Opinion: Medically tailored meals save lives. Health plans should cover their cost
If nutritious meals can provide the same kind of benefit as medication, then why don’t…
Cancer deaths cost the U.S. $94 billion in lost earnings in a single year
Cancer is estimated to have caused more than 600,000 deaths in 2015, inflicting a toll…
STAT Plus: Some insurers are pushing back on the high price for a Novartis gene therapy
Barely a month after Novartis (NVS) won U.S. regulatory approval for its gene therapy —…
STAT Plus: Too many drug makers and universities fail to report trial results in Europe
A large percentage of drug makers, universities, and hospitals continue to fail to publicly post…
FDA approves new multiple myeloma drug despite toxicity concerns
The Food and Drug Administration on Wednesday approved a new drug to treat patients with…
STAT Plus: Stem-cell biotech seeing strong growth
CAMBRIDGE, Mass. — In February 2016, Japanese drug maker Astellas Pharma paid $379 million for…
STAT Plus: Pharmalittle: Trump grows frustrated over drug pricing; FDA enforcement declines under Trump
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
.jpg)
Opinion: Oncologists are guardedly optimistic about AI. But will it drive real improvements in cancer care?
Over the course of my 25-year career as an oncologist, I’ve witnessed a lot of…
.jpg)
STAT Plus: 5 names to know in digital therapeutics: the people behind apps that work like medicines
No one really knew what digital therapeutics were 10 years ago. Today, there’s still no…
HHS gets a new HIV prevention patent, but will the agency demand royalties from Gilead?
For the past several months, the U.S. government has been lambasted by AIDS activists for…
STAT Plus: Digging into the FDA’s grievance hotline
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
STAT Plus: Researchers use CRISPR to eliminate HIV in mice
The most advanced drugs for HIV suppress the virus, essentially rendering it a chronic disease…
Elizabeth Warren blasts former FDA commissioner for joining Pfizer’s board
WASHINGTON — Sen. Elizabeth Warren on Tuesday called for Scott Gottlieb, who resigned as commissioner…
STAT Plus: Pharmalittle: Drug prices rose 10.5% this year; Senate committee probes groups tied to opioid makers
Rise and shine, everyone, another busy day is on the way. Despite the short week…
STAT Plus: Novo Nordisk’s Jorgensen: If it was easy to correct pricing, we would be doing it already
Until the rising national anger over the cost of medicines, Novo Nordisk (NVO) retained a…
Amarin raises sales guidance for heart drug Vascepa, hires more sales reps for larger marketing push
Amarin (AMRN) pre-announced record quarterly sales of its heart drug Vascepa on Tuesday and raised…
New guidelines aim to enlist primary care physicians in transgender care
In a move that reflects a growing acceptance of transgender individuals in the U.S., the…
STAT Plus: Senators widen probe into groups with ties to opioid makers
The Senate Finance Committee is widening a probe into tax-exempt organizations — including patient advocacy…
STAT Plus: Lawmakers seek more info on how FDA inspects plants in China and India
Amid ongoing interest among Americans to import drugs from other countries as well as continuing…
STAT Plus: Lawmakers seek more info on how FDA inspects plants in China and India
Amid ongoing interest among Americans to import drugs from other countries as well as continuing…
STAT Plus: The race for a better Duchenne treatment: Adam and Matt talk Pfizer, Sarepta, and gene therapy
On Friday, Pfizer presented the first results in humans for its gene therapy to treat…
STAT Plus: The race for a better Duchenne treatment: Adam and Matt talk Pfizer, Sarepta, and gene therapy
On Friday, Pfizer presented the first results in humans for its gene therapy to treat…
The boy was dying. Zebrafish helped save his life
The boy was quickly running out of options. His legs and belly were swelling like…
The boy was dying. Zebrafish helped save his life
The boy was quickly running out of options. His legs and belly were swelling like…
STAT Plus: Pharmalittle: American Pain Society to end operations; first state drug affordability board starts
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: American Pain Society to end operations; first state drug affordability board starts
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
‘Sickle cell needs more funding’: An 18-year-old patient advocate calls on Washington to improve children’s health care
Sydney McLeod left her college dorm in New Jersey to rush to the emergency room,…
‘Sickle cell needs more funding’: An 18-year-old patient advocate calls on Washington to improve children’s health care
Sydney McLeod left her college dorm in New Jersey to rush to the emergency room,…
Opinion: Patient-innovators fill gaps that industry hasn’t addressed — or can’t
Here’s a long-held assumption that’s ripe for a challenge: Valuable improvements in health and patient…
Opinion: Patient-innovators fill gaps that industry hasn’t addressed — or can’t
Here’s a long-held assumption that’s ripe for a challenge: Valuable improvements in health and patient…
STAT Plus: The biotech scorecard for the third quarter: 12 stock-moving events to watch
Here is STAT’s Biotech Scorecard, our regular ledger of stock-moving biotech events, for the third…
Ex-Theranos CEO Elizabeth Holmes gets a trial date: summer 2020
SAN FRANCISCO — The criminal trial of ex-Theranos CEO Elizabeth Holmes has been scheduled to…
STAT Plus: What the Democrats said about ‘big pharma’ — and why it matters
WASHINGTON — Practically the first words spoken at the first Democratic primary debate on Wednesday…
Diabetes-coaching startup Livongo files to go public in a test for health tech
Livongo, a startup that monitors and coaches patients with chronic diseases, on Friday filed papers…
Scott Gottlieb walks through the revolving door to the Pfizer board
The revolving door turns again. After a two-year stint running the Food and Drug Administration,…
Listen: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
Can Botox make Big Pharma attractive? What qualifies as a “cabal”? And will the CRISPR…
STAT Plus: Making music from proteins to better understand biology
Imagine listening to insulin, hemoglobin, or amyloid, the notorious Alzheimer’s protein. What do they sound…
STAT Plus: Doctors Without Borders accuses Gilead Sciences of breaking a pledge for an HIV-related drug
Ten months after pledging to expand a discount program for a drug that treats an…
Flu vaccine no match against bug that popped up near end
ATLANTA — The flu vaccine turned out to be a big disappointment again. The vaccine…
STAT Plus: Pharmalittle: Judges keep pharma secrets under wraps; Senate committees push drug pricing bills
Top of the morning to you, and a fine one it is. A cool breeze…
Opinion: Presidential candidates should be ready to discuss plans for infectious diseases
As the legion of Democratic presidential candidates face off this week, they will be addressing…
San Francisco is first major U.S. city to ban e-cigarettes
SAN FRANCISCO — San Francisco became the first major U.S. city to ban the sale…
Consumer genetic testing companies team up to lobby on privacy policy
Anticipating more federal scrutiny of genetic privacy policies, three leading consumer genetic companies have formed…